Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04397939 · ClinicalTrials.gov registry record
Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 4,695
- Enrollment target
NCT04397939: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT04397939 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 4,695 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04397939 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 4,695 participants
- Enrollment target
Study Summary
The study will analyze the incidence, clinical outcomes and predictors of myocardial injury in a large patient population with COVID-19 treated in Mount Sinai Hospital (MSH) system. In addition, the study team will explore the association between high-sensitivity troponin I (TnI) levels and clinical characteristics, biomarkers, cardiac tests data and treatment approaches to uncover the potential mechanisms responsible for COVID-19 induced myocardial injury.
Primary Outcome
Number of deaths at 6 months follow up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,695 participants |
| Start Date | 2020-05-08 |
| Est. Completion | 2022-03-01 |
What the finished NCT04397939 record still lists
NCT04397939 is an observational study that tracks outcomes without assigning an intervention. Its 4,695 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04397939 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04397939 about?
NCT04397939 is a clinical study titled "Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19". The study will analyze the incidence, clinical outcomes and predictors of myocardial injury in a large patient population with COVID-19 treated in Mount Sinai Hospital (MSH) system. In addition, the study team will explore the association between high-sensitivity troponin I (TnI) levels and clinical...
What is the current status of trial NCT04397939?
This trial is currently completed. The enrollment target is 4,695 participants. The study started on 2020-05-08. Estimated completion is 2022-03-01.
Who is sponsoring clinical trial NCT04397939?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04371900 · 4,700 participants · NA
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
- NCT05486572 · 4,700 participants · NA
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- NCT06888388 · 4,700 participants
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
- NCT06535139 · 4,630 participants · NA
ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI